PREFACE ........................................................ ix
CONTRIBUTORS ................................................... xi
PART I GENERAL ASPECTS
1 ToxCast: Predicting Toxicity Potential Through High-
Throughput Bioactivity Profiling ............................. 3
Keith A. Houck, Ann M. Richard, Richard S. Judson, Matthew
T. Martin, David M. Reif, and Imran Shah
2 High-Throughput Toxicity Testing in Drug Development:
Aims, Strategies, and Novel Trends .......................... 33
Willem G.E.J. Schoonen, Walter M.A. Westerink, Femke M.
van de Water, and Horbach G. Jean
3 Incorporating Human Dosimetry and Exposure Information
with High-Throughput Screening Data in Chemical Toxicity
Assessment .................................................. 77
Barbara A. Wetmore and Russell S. Thomas
4 The Use of Human Embryonic Stem Cells in High-Throughput
Toxicity Assays ............................................. 97
Xin Huang, Dan-yan Zhu, and Yi-jia Lou
PART II HIGH-THROUGHPUT ASSAYS TO ASSESS DIFFERENT
CYTOTOXICITY ENDPOINTS
5 High-Throughput Screening Assays for the Assessment of
Cytotoxicity ............................................... 109
Andrew L. Niles, Richard A. Moravec, Tracy
J. Worzella, Nathan J. Evans, and Terry L. Riss
6 High-Throughput Flow Cytometry Analysis of
Apoptosis .................................................. 129
Francesca de Giorgi and Francois Ichas
7 High Content Imaging-Based Screening for Cellular
Toxicity Pathways .......................................... 143
Bram Herpers and Bob van de Water
8 The Keratinosens Assay: A High-Throughput Screening
Assay to Assess Chemical Skin Sensitization ................ 159
Andreas Natsch
9 High-Throughput Screening Assays to Assess Chemical
Phototoxicity .............................................. 177
Satomi Onoue, Yoshiki Seto, and Shizuo Yamada
PART III HIGH-THROUGHPUT ASSAYS TO ASSESS DNA DAMAGE AND
CARCINOGENESIS
10 Ames IITM and Ames Liquid Format Mutagenicity Screening
Assays ..................................................... 193
Kamala Pant
11 High-Throughput Bacterial Mutagenicity Testing: VitotoxTM
Assay ...................................................... 213
Luc Verschaeve
12 Genotoxicity and Carcinogenicity: Regulatory and Novel
Test Methods ............................................... 233
Walter M.A. Westerink, Joe C.R. Stevenson, G. Jean
Horbach, Femke M. van de Water, Beppy van de Waart, and
Willem G.E.J. Schoonen
13 High-Throughput Genotoxicity Testing: The Greenscreen
Assay ...................................................... 271
Jörg Bliimel and Nadine Krause
14 High-Throughput Assays to Quantify the Formation of
DNA Strand Breaks .......................................... 285
María Moreno-Villanueva and Alexander Bürkle
15 High-Throughput Versions of the Comet Assay ................ 295
Irene Witte and Andrí Stang
16 Automated Soft Agar Colony Formation Assay for the
High-Throughput Screening of Malignant Cell
Transformation ............................................. 309
Pablo Steinberg
17 High-Throughput Quantification of Morphologically
Transformed Foci in Bhas 42 Cells (v-Ha-ras Transfected
BALB/c 3T3) Using Spectrophotometry ........................ 317
Kiyoshi Sasaki, Ayako Sakai, and Noriho Tanaka
PART IV HIGH-THROUGHPUT ASSAYS TO ASSESS REPRODUCTIVE
TOXICITY, CARDIOTOXICITY, AND HAEMATOTOXICITY
18 ReProGlo: A New Stem-Cell-Based High-Throughput Assay to
Predict the Embryotoxic Potential of Chemicals ............. 343
Frederik Uibel and Michael Schwarz
19 Embryonic Stem Cell Test (EST): Molecular Endpoints
Toward High-Throughput Analysis of Chemical Embryotoxic
Potential .................................................. 357
Peter T. Theunissen, Esther de Jong, Joshua F. Robinson,
and Aldert H. Piersma
20 Zebrafish Development: High-Throughput Test Systems to
Assess Developmental Toxicity .............................. 371
Stephanie Padilla
21 Single Cell Imaging Cytometry-Based High-Throughput
Analysis of Drug-Induced Cardiotoxicity .................... 385
Min Jung Kim and Joon Myong Song
22 High-Throughput Screening Assays to Evaluate the
Cardiotoxic Potential of Drugs ............................. 403
Carl-Fredrik Mandenius and Thomas Meyer
23 High-Throughput Screening Assays to Evaluate the
Hematotoxic Potential of Drugs ............................. 421
Caroline Haglund, Rolf Larsson, and Martin Höglund
PART V HIGH-THROUGHPUT ASSAYS TO ASSESS DRUG METABOLISM
AND RECEPTOR-RELATED TOXICITY
24 High-Throughput Enzyme Biocolloid Systems for Drug
Metabolism and Genotoxicity Profiling Using LC-MS/MS ....... 433
James F. Rusling and John Schenkman
25 Higher-Throughput Screening Methods to Identify
Cytochrome P450 Inhibitors and Inducers: Current
Applications and Practice .................................. 453
David M. Stresser and George Zhang
26 High-Throughput Yeast-Based Assays to Study Receptor-
Mediated Toxicity .......................................... 479
Johanna Rajasdrkka and Marko Vina
27 Evaluating the Peroxisomal Phenotype in High Content
Toxicity Profiling ......................................... 501
Jonathan Z. Sexton and Kevin P. Williams
28 A Panel of Quantitative Calux® Reporter Gene Assays for
Reliable High-Throughput Toxicity Screening of Chemicals
and Complex Mixtures ....................................... 519
Bart van der Burg, Sander van der Linden, Hai-yen Man,
Roos Winter, Lydia Jonker, Barbara van Vugt-Lussenburg,
and Abraham Brouwer
29 DR-Calux®: A High-Throughput Screening Assay for the
Detection of Dioxin and Dioxin-Like Compounds in Food
and Feed ................................................... 533
Barbara van Vugt-Lussenburg, Harrie T. Besselink, Bart
van der Burg, and Abraham Brouwer
INDEX ......................................................... 547
|